Latest filing published 31 Dec 2015 for Calithera Biosciences, Inc., €532.
Insider track record
No signal scores available.
Mark K. Bennett: trading record in brief
Mark K. Bennett discloses dealings in Calithera Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 8 July 2015 to 29 December 2015, the count stands at 8 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 31 December 2015, reports an option exercise of €532 in Calithera Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark K. Bennett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,217 shares@ US$0.48Common StockSEC:0001209191-15-087496:0
- 1,612 shares@ US$0.48Common StockSEC:0001209191-15-087496:1
- 2,835 shares@ US$0.96Common StockSEC:0001209191-15-087496:2
- 4,749 shares@ US$2.64Common StockSEC:0001209191-15-087496:3
- 3,039 shares@ US$0.48Common StockSEC:0001209191-15-060547:0
- 2,688 shares@ US$0.48Common StockSEC:0001209191-15-060547:1
- 4,726 shares@ US$0.96Common StockSEC:0001209191-15-060547:2
- 7,912 shares@ US$2.64Common StockSEC:0001209191-15-060547:3
8 of 8 declarations
